日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacological modulation of inflammatory oligodendrocyte progenitor cells using three multiple sclerosis disease modifying therapies in vitro

体外使用三种多发性硬化症疾病改良疗法对炎症少突胶质细胞祖细胞进行药理调节

Larissa Jank, Riley B Catenacci, Veronica Minney, Danny Galleguillos, Peter A Calabresi

MHC class I and MHC class II reporter mice enable analysis of immune oligodendroglia in mouse models of multiple sclerosis

MHC I类和MHC II类报告基因小鼠能够分析多发性硬化症小鼠模型中的免疫少突胶质细胞

Em P Harrington # ,Riley B Catenacci # ,Matthew D Smith ,Dongeun Heo ,Cecilia E Miller ,Keya R Meyers ,Jenna Glatzer ,Dwight E Bergles ,Peter A Calabresi